Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus-Reference-Cited by-同舟云学术

Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus

Published:2014-04 Issue:4 Volume:58 Page:219-226
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:Microbiol Immunol

Author:

Lazo Laura¹,Izquierdo Alienys²,Suzarte Edith¹,Gil Lázaro¹,Valdés Iris¹,Marcos Ernesto¹,Álvarez Mayling²,Romero Yaremis¹,Guzmán María Guadalupe²,Guillén Gerardo¹,Hermida Cruz Lisset¹

Affiliation:

1. Vaccines Division; Center for Genetic Engineering and Biotechnology; P.O. Box 6162 Playa Havana 11 600 Cuba

2. Virology Department; Tropical Medicine Institute “Pedro Kourí,” Pan American Health Organization/World Health Organization Collaborating Center for the Study of Dengue and its Vector; P.O. Box Marianao 13 Havana 11 600 Cuba

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1348-0421.12140/fullpdf

Reference34 articles.

1. Pathogenesis: Risk Factors Prior to Infection

2. A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates;Chen;Arch Virol,2013

3. Short report: antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine;Simmons;Am J Trop Med Hyg,2001

4. A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice;Valdes;Virology,2009

5. Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III;Chiang;Microbes Infect,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches of dengue control: vaccine strategies and future aspects;Frontiers in Immunology;2024-02-29

2. Designing of a multiepitope-based chimeric vaccine against dengue virus serotype 3 (DENV-3) through next generation reverse vaccinology approaches;Informatics in Medicine Unlocked;2024

3. Targets and strategies for vaccine development against dengue viruses;Biomedicine & Pharmacotherapy;2021-12

4. Morphological Aspects and Viremia Analysis of BALB/c Murine Model Experimentally Infected with Dengue Virus Serotype 4;Viruses;2021-09-29

5. Dengue vaccine: an update;Expert Review of Anti-infective Therapy;2021-07-13